Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Combined With Radiotherapy in Esophageal Cancer
NCT01368419Phase 2Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- May 2011
- Primary completion
- May 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in esophageal cancer, sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
endostar
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01368419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368419.